- Home
- IKT vs SPCE Comparison
IKT vs SPCE Comparison
Compare IKT & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- SPCE
- Stock Information
- Founded
- IKT 2008
- SPCE 2017
- Country
- IKT United States
- SPCE United States
- Employees
- IKT N/A
- SPCE N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- IKT Health Care
- SPCE Consumer Discretionary
- Exchange
- IKT Nasdaq
- SPCE Nasdaq
- Market Cap
- IKT 140.5M
- SPCE 148.0M
- IPO Year
- IKT 2020
- SPCE N/A
- Fundamental
- Price
- IKT $1.80
- SPCE $3.16
- Analyst Decision
- IKT Buy
- SPCE Hold
- Analyst Count
- IKT 2
- SPCE 5
- Target Price
- IKT $8.00
- SPCE $11.05
- AVG Volume (30 Days)
- IKT 528.7K
- SPCE 2.4M
- Earning Date
- IKT 08-13-2025
- SPCE 08-06-2025
- Dividend Yield
- IKT N/A
- SPCE N/A
- EPS Growth
- IKT N/A
- SPCE N/A
- EPS
- IKT N/A
- SPCE N/A
- Revenue
- IKT N/A
- SPCE $5,512,000.00
- Revenue This Year
- IKT N/A
- SPCE N/A
- Revenue Next Year
- IKT N/A
- SPCE $4,110.27
- P/E Ratio
- IKT N/A
- SPCE N/A
- Revenue Growth
- IKT N/A
- SPCE N/A
- 52 Week Low
- IKT $1.12
- SPCE $2.18
- 52 Week High
- IKT $4.20
- SPCE $8.29
- Technical
- Relative Strength Index (RSI)
- IKT 45.45
- SPCE 55.45
- Support Level
- IKT $1.81
- SPCE $2.72
- Resistance Level
- IKT $2.09
- SPCE $2.91
- Average True Range (ATR)
- IKT 0.14
- SPCE 0.14
- MACD
- IKT 0.01
- SPCE 0.05
- Stochastic Oscillator
- IKT 45.28
- SPCE 71.64
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.